Search

for
Search:

Learn

0 / 0 results

— no results

Research

1 / 1 results

research Evaluating 5 Alpha Reductase Inhibitors for the Treatment of Male Androgenic Alopecia

November 2023 in “Expert Opinion on Pharmacotherapy”

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Community Join

4 / 4 results

community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases

hzah1 in Research/Science 35 upvotes 9 months ago

Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.

community All Drugs in Clinical Trials in 2023

FollicleThought_com in Research/Science 69 upvotes 2 years ago

12 companies having drugs or therapies in clinical trials during 2023, with various molecules and phases of trial; the probability that some may fail; and progress being made in the field.

community There’s actually a quite good chance that next year, we might see a new treatment get FDA approval for the first time in nearly three decades.

bentreehorn in Research/Science 77 upvotes 4 days ago

Breezula, a potential new hair loss treatment, may receive FDA approval soon, but it is expected to be a weaker alternative to finasteride and minoxidil. Concerns include its twice-daily application and possible side effects like HPA axis suppression.

community I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.

noeyys in Research/Science 152 upvotes 1 month ago

GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.